Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

Condition:   Asthma
Interventions:   Biological: Benralizumab;   Other: Placebo
Sponsor:   AstraZeneca
Not yet recruiting – verified June 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *